Zhigang Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zhigang Zhou has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- David J. Finkl
Department of Neurology, University of Michigan and VA Ann Arbor Healthcare System, Ann Arbor, MI, USA
2 shared publications - Marina Mata
Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA
2 shared publications - Jeeyong Kim
Department of Neurology, University of Michigan and VA Ann Arbor Healthcare System (Neurology and GRECC), 5027 BSRB 109 Zina Pitcher Place, Ann Arbor, MI 48109, USA
1 shared publication - Munmun Chattopadhyay
Department of Molecular and Translational Medicine, Center of Emphasis in Diabetes and Metabolism, Texas Tech University Health Sciences Center, 5001 El Paso Drive, El Paso, Texas 79905, United States
1 shared publication - Ryan Insolera
Wayne State University
1 shared publication - Shuanglin Hao
Department of Anesthesiology, University of Miami Miller School of Medicine, Miami, FL, USA
1 shared publication
Latest Publications
- Open Access
- 1 January 2012
- Published by SAGE Publications in Molecular Pain
- Vol. 8, 17
Reduction of Voltage Gated Sodium Channel Protein in DRG by Vector Mediated miRNA Reduces Pain in Rats with Painful Diabetic Neuropathy
Background: Painful neuropathy is a common complication of diabetes. Previous studies have identified significant increases in the amount of voltage gated sodium channel isoforms NaV1.7 and NaV1.3 protein in the dorsal root ganglia (DRG) of rats with streptozotocin (STZ)-induced diabetes. We found that gene transfer-mediated release of the inhibitory neurotransmitters enkephalin or gamma amino butyric acid (GABA) from DRG neurons in diabetic animals reduced pain-related behaviors coincident with a reduction in NaV1.7 protein levels in DRG in vivo. To further evaluate the role of NaVα subunit levels in DRG in the pathogenesis of pain in diabetic neuropathy, we constructed a nonreplicating herpes simplex virus (HSV)-based vector expressing a microRNA (miRNA) against NaVα subunits. Results: Subcutaneous inoculation of the miRNA-expressing HSV vector into the feet of diabetic rats to transduce DRG resulted in a reduction in NaVα subunit levels in DRG neurons, coincident with a reduction in cold allodynia, thermal hyperalgesia and mechanical hyperalgesia. Conclusions: These data support the role of increased NaVα protein in DRG in the pathogenesis of pain in diabetic neuropathy, and provide a proof-of-principle demonstration for the development of a novel therapy that could be used to treat intractable pain in patients with diabetic neuropathy.
- 1 January 2012
- Published by SAGE Publications in Molecular Pain
- Vol. 8, 17
Open AccessReduction of Voltage Gated Sodium Channel Protein in DRG by Vector Mediated miRNA Reduces Pain in Rats with Painful Diabetic Neuropathy
Background: Painful neuropathy is a common complication of diabetes. Previous studies have identified significant increases in the amount of voltage gated sodium channel isoforms NaV1.7 and NaV1.3 protein in the dorsal root ganglia (DRG) of rats with streptozotocin (STZ)-induced diabetes. We found that gene transfer-mediated release of the inhibitory neurotransmitters enkephalin or gamma amino butyric acid (GABA) from DRG neurons in diabetic animals reduced pain-related behaviors coincident with a reduction in NaV1.7 protein levels in DRG in vivo. To further evaluate the role of NaVα subunit levels in DRG in the pathogenesis of pain in diabetic neuropathy, we constructed a nonreplicating herpes simplex virus (HSV)-based vector expressing a microRNA (miRNA) against NaVα subunits. Results: Subcutaneous inoculation of the miRNA-expressing HSV vector into the feet of diabetic rats to transduce DRG resulted in a reduction in NaVα subunit levels in DRG neurons, coincident with a reduction in cold allodynia, thermal hyperalgesia and mechanical hyperalgesia. Conclusions: These data support the role of increased NaVα protein in DRG in the pathogenesis of pain in diabetic neuropathy, and provide a proof-of-principle demonstration for the development of a novel therapy that could be used to treat intractable pain in patients with diabetic neuropathy.
- 1 September 2011
- Published by Elsevier in Molecular and Cellular Neuroscience
- Vol. 48 (1) , 29-37
Rho GTPase regulation of α-synuclein and VMAT2: Implications for pathogenesis of Parkinson's disease
- 1 September 2011
- Published by Elsevier in Molecular and Cellular Neuroscience
- Vol. 48 (1) , 29-37
Rho GTPase regulation of α-synuclein and VMAT2: Implications for pathogenesis of Parkinson's disease